Thyssenkrupp Steel, Labor Union Reach Agreement on Job Cuts
The deal secures long-term investments, limits outsourcing and gives labor representatives a say in efficiency measures, marking a key step in the company's turnaround effort, the IG Metall union said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Lido Advisors Completes Strategic Investment from HPS to Support Continued Growth
LOS ANGELES, August 07, 2025--(BUSINESS WIRE)--Lido Advisors ("Lido"), a leading wealth advisory firm with over $30 billion in regulatory assets under management, today announced the closing of its strategic investment from funds managed by HPS Investment Partners ("HPS"). HPS joins Lido's existing investors Charlesbank Capital Partners ("Charlesbank") and Constellation Wealth Capital ("CWC"), along with Lido's more than 160 employee-owners, to support the firm's continued growth and client-first mission. "Today marks a milestone moment for Lido, our team, and our clients," said Jason Ozur, Chief Executive Officer of Lido. "I'm incredibly proud of the growth we've achieved while staying true to our client-first values, and I am excited to embark on the next phase of Lido's journey with the additional support of HPS. Lido is extremely well positioned to continue our momentum and to further enhance the personalized, family office-style experience we provide our clients." Ardea Partners LP served as lead financial advisor, and William Blair & Company LLC served as financial advisor to Lido. Houlihan Lokey and Piper Sandler & Co. also provided financial advice. Ropes & Gray LLP served as legal counsel to Lido and Charlesbank. Herrick, Feinstein LLP and Willkie Farr & Gallagher LLP also provided legal advice. Gibson Dunn & Crutcher LLP served as legal counsel to CWC. Sidley Austin LLP served as legal counsel to HPS. About Lido AdvisorsLido Advisors is a nationally recognized wealth advisory firm headquartered in Los Angeles, California, with $33.5 billion in regulatory assets under management as of June 30, 2025, and 40 offices across the United States. The firm embraces an active approach to asset management focused on risk mitigation and access to alternative, core, and tactical investment strategies. Lido provides a family office experience to its clients with a deep commitment to personalized, comprehensive wealth planning and access to affiliated professionals providing estate and tax planning, and legacy solutions. Lido is focused on creating an innovative, high-touch client experience and becoming its clients' financial life partner. For more information, visit About HPS Investment PartnersHPS Investment Partners, LLC is a leading global, credit-focused alternative investment firm that seeks to provide creative capital solutions and generate attractive risk-adjusted returns for our clients. We manage various strategies across the capital structure, including privately negotiated senior debt; privately negotiated junior capital solutions in debt, preferred and equity formats; liquid credit including syndicated leveraged loans, collateralized loan obligations and high yield bonds; asset-based finance and real estate. The scale and breadth of our platform offers the flexibility to invest in companies large and small, through standard or customized solutions. At our core, we share a common thread of intellectual rigor and discipline that enables us to create value for our clients, who have entrusted us with approximately $157 billion of assets under management as of March 31, 2025. For more information, visit About Charlesbank Capital PartnersFounded in 1998, Charlesbank Capital Partners is a leading middle-market private investment firm with approximately $20 billion of assets under management as of March 31, 2025. Drawing on nearly three decades of experience and sector insights, the firm takes a thematic approach to investing across its target sectors: business and consumer services, healthcare, industrial and technology. Charlesbank partners with talented management teams to help businesses unlock value and accelerate growth, with a focus on long-term value creation. The firm provides flexible capital through complementary strategies spanning management-led buyouts, opportunistic credit and technology investments. Charlesbank has offices in Boston and New York. For more information, visit or follow Charlesbank on LinkedIn. About Constellation Wealth CapitalConstellation Wealth Capital (CWC) is an alternative asset management platform dedicated to the wealth management sector. CWC provides flexible, long-term capital solutions and strategic advisory support to scaled wealth management platforms, leveraging deep industry expertise and an extensive network of relationships to help partner firms accelerate growth and create long-term value. For more information, visit View source version on Contacts MediaFor Lido Advisors Sarah TremalloJConnelly908-967-0381lidoadvisors@ For HPS Investment Partners Mike Geller / Josh ClarksonProsek Partners646-818-9018 / 646-818-9259pro-hps@ For Charlesbank Ryan FitzGibbon / Alexa Ottenstein / Peter GavarisProsek Partnerspro-charlesbank@ For Constellation Wealth Capital Mike GellerProsek Partners646-818-9018mgeller@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
Are Wall Street Analysts Predicting Berkshire Hathaway Stock Will Climb or Sink?
Valued at a market cap of $1 trillion, Berkshire Hathaway Inc. (BRK.B) owns a diverse range of businesses across sectors, including insurance, energy, railroads, manufacturing, consumer goods, and retail. The Omaha, Nebraska-based company also maintains a substantial equity investment portfolio. This multinational conglomerate has lagged behind the broader market over the past 52 weeks. Shares of BRK.B have gained 11.1% over this time frame, while the broader S&P 500 Index ($SPX) has surged 21.1%. Moreover, on a YTD basis, the stock is up 3.5%, compared to SPX's 7.9% uptick. More News from Barchart Supermicro's Earnings Selloff Explained: Should You Buy SMCI Stock Now? Amazon's $36M Bet on Quantum Computing: What Investors Need to Know AMD Stock Slips After Q2 Earnings, But Here's Why It's a Buying Opportunity Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. Narrowing the focus, BRK.B has also underperformed the iShares U.S. Financial Services ETF's (IYG) 32% rise over the past 52 weeks and 10.6% return on a YTD basis. Berkshire Hathaway delivered its Q2 results on Aug. 2, and its shares plunged 2.9% in the following trading session. Due to lower insurance sales and service revenues, the company's top-line fell 1.2% year-over-year to $92.5 billion. Furthermore, its operating earnings declined 3.8% from the year-ago quarter to $11.2 billion, fueled by a 12% drop in insurance underwriting income. For the current fiscal year, ending in December, analysts expect BRK.B's EPS to decline 6.7% year over year to $20.53. The company's earnings surprise history is disappointing. It missed the consensus estimates in three of the last four quarters, while exceeding on another occasion. Among the six analysts covering the stock, the consensus rating is a "Moderate Buy' which is based on two 'Strong Buy,' and four 'Hold' ratings. The configuration has remained consistent over the past three months. On Aug. 4, UBS Group AG (UBS) analyst Brian Meredith maintained a "Buy" rating on BRK.B and raised its price target to $597, the Street-high price target, implying an ambitious 27.3% potential upside from the current levels. The mean price target of $539.25 represents a 15% premium from BRK.B's current price levels. On the date of publication, Neharika Jain did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
2 minutes ago
- Yahoo
Avidity (RNA) Gets 26% Jump on Potential Takeover
We recently published . Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the best-performing stocks on Wednesday. Avidity Biosciences rallied for a third day on Wednesday, jumping 26.14 percent to close at $48.26 as investors gobbled up shares following reports that it received an acquisition bid from Swiss drugmaker Novartis AG (NYSE:NVS). A report by the Financial Times, citing people privy to the matter, said that Novartis AG (NYSE:NVS) offered Avidity Biosciences, Inc. (NASDAQ:RNA) to acquire the company, in line with the former's plans to boost its pipeline of medicines targeting rare genetic disorders. Meanwhile, the report said that Avidity Biosciences, Inc. (NASDAQ:RNA) was mulling over the offer, although the talks could still collapse as other companies have emerged with separate takeover offers. Late last month, Avidity Biosciences, Inc. (NASDAQ:RNA) secured a Breakthrough Therapy designation from the Food and Drug Administration for its del-zota treatment for Duchenne muscular dystrophy (DMD) in patients with DMD44. DMD is a rare genetic condition characterized by progressive muscle damage and weakness due to the loss of dystrophin protein that typically starts at a young age. Del-zota, on the other hand, was designed to deliver phosphorodiamidate morpholino oligomers (PMOs) to skeletal muscle and heart tissue to specifically skip exon 44 of the dystrophin gene and enable production of near-full length dystrophin. While we acknowledge the potential of RNA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
